Phibro Animal Health Corporation Class A
PAHCPhibro Animal Health Corporation Class A (PAHC) is a global provider of innovative solutions, including vaccines, medicines, mineral feed additives, and other products aimed at improving the health and performance of animals. Founded in 1946, the company serves the livestock, poultry, and aquaculture industries with a focus on sustainability and advancing animal well-being through a broad portfolio of pharmaceutical and nutritional products.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 17, 2025 | $0.12 | 2025-11-26 | 2025-11-26 |
| September 24, 2025 | $0.12 | 2025-09-03 | 2025-09-03 |
| June 25, 2025 | $0.12 | 2025-06-04 | 2025-06-04 |
| March 26, 2025 | $0.12 | 2025-03-05 | 2025-03-05 |
| December 18, 2024 | $0.12 | 2024-11-27 | 2024-11-27 |
Dividends Summary
- Consistent Payer: Phibro Animal Health Corporation Class A has rewarded shareholders with 46 dividend payments over the past 11 years.
- Total Returned Value: Investors who held PAHC shares during this period received a total of $5.18 per share in dividend income.
- Latest Payout: The most recent dividend of $0.12/share was paid 37 days ago, on December 17, 2025.
- Yield & Schedule: PAHC currently pays dividends quarterly with an annual yield of 1.23%.
- Dividend Growth: Since 2014, the dividend payout has grown by 20.0%, from $0.10 to $0.12.
- Dividend Reliability: PAHC has maintained or increased its dividend for 46 consecutive payments.
Company News
The global glycolic acid market is projected to grow at a CAGR of 5.73% from 2026 to 2032, reaching USD 461.74 Million by 2032, up from USD 295.68 Million in 2024. Growth is driven by increasing demand in personal care, pharmaceuticals, and industrial cleaning applications, though regulatory challenges and raw material price volatility pose restr...
Phibro Animal Health reported strong Q4 FY2025 earnings, with 39% revenue growth driven by the Zoetis medicated feed additive acquisition. Despite robust sales and adjusted EBITDA, gross margins declined due to higher distribution costs and product mix challenges.
The article recommends two value stocks to buy for February 14th: Adtalem Global Education (ATGE) and Phibro Animal Health (PAHC). Both companies have a Zacks Rank #1 and have seen their earnings estimates increase in the last 60 days, indicating positive sentiment.
The poultry pharmaceuticals market is dominated by vaccines due to rising concerns over infectious diseases and regulatory restrictions on antibiotics. The market is projected to reach $6.68 billion by 2029, driven by increasing poultry consumption and the need for effective disease management.
The porcine vaccine market is forecasted to grow by USD 709.6 million during 2023-2028, driven by increasing prevalence of porcine diseases, research and development, and growing animal healthcare expenditure.
